# Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy

> **NCT01834040** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chaitanya Hospital, Pune** · enrollment: 30 (estimated)

## Conditions studied

- Muscular Dystrophy
- Duchenne Muscular Dystrophy

## Interventions

- **OTHER:** Intralesional/ Intravenous of Autologous Stem cells.

## Key facts

- **NCT ID:** NCT01834040
- **Lead sponsor:** Chaitanya Hospital, Pune
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2016-09
- **Final completion:** 2016-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01834040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01834040, "Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01834040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*